News
4d
InvestorsHub on MSNNovo Nordisk appoints Mike Doustdar as new CEO; Chief Scientific Officer to retireNovo Nordisk (NYSE:NVO) announced on Tuesday that Maziar Mike Doustdar will become its new president and chief executive ...
Founder Jeremy Brown, Ph.D. to continue as Chief Technical Officer, driving scientific vision HALIFAX, NS, July 31, 2025 /CNW/ — Sound Blade Medical, Inc., a leader in handheld histotripsy ...
Dr. Hodous, chief scientific officer, noted, “It has been deeply gratifying to witness the evolution of what began as a formidable scientific challenge—targeting SH2 domains as a therapeutic ...
Professor Robin May will step down as the FSA’s Chief Scientific Adviser in September to become Interim Chief Scientific ...
Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable precision radiopharmaceuticals for ...
Experienced academic has been Food Standards Agency Chief Scientific Adviser for the last five years and will move to UKHSA ...
CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Jun 9, 2025--Fable Therapeutics Appoints David J. Baker, PhD, as Chief Scientific Officer ...
Investing.com -- Novo Nordisk (NYSE: NVO) has appointed Maziar Mike Doustdar as its new president and chief executive officer, effective August 7, 2025, the company announced on Tuesday.
3d
MyChesCo on MSNAclaris Therapeutics Taps Veteran Biotech Leader Roland Kolbeck as New Chief Scientific OfficerAclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the appointment of Roland Kolbeck, Ph.D., as its new Chief Scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results